MSCIS suitable for phacolytic glaucoma patients

Article

Manual small incision cataract surgery (MSCIS) with trypan blue staining of the anterior capsule is a safe and effective method of cataract extraction for patients with phacolytic glaucoma.

Manual small incision cataract surgery (MSCIS) with trypan blue staining of the anterior capsule is a safe and effective method of cataract extraction for patients with phacolytic glaucoma, according to a report published in the March issue of the British Journal of Ophthalmology.

Rengaraj Venkatesh and colleagues from the Aravind Eye Hospital, India and the Eye Institute at Tan Tock Seng Hospital, Singapore, conducted a non-randomized interventional case series of three patients with phacolytic glaucoma undergoing cataract extraction by MSICS, with trypan blue staining of the anterior capsule.

The mean preoperative intraocular pressure (IOP) was 46.2 mmHg. In 31 patients, an intraocular lens (IOL) was implanted in the posterior chamber and in the further two subjects, the posterior capsule was removed leaving aphakia due to severe pre-existing zonulysis. Postoperative best corrected visual acuity (BCVA) was 20/60 or better in 29 patients and 20/40 or better in 26 patients. In all 33 cases, the IOP was 22 mmHg or less without the use of anti-glaucoma medications (mean IOP was 15.1 mmHg). Postoperative corneal oedema occurred in 11 cases and anterior chamber inflammation was noted in nine cases. Both were resolved with standard medical therapy.

The authors of the study concluded that MSCIS with trypan blue staining is a safe and effective method of extracting cataracts in patients with phacolytic glaucoma.

Newsletter

Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

Recent Videos
Christine Curcio, PhD, of the University of Alabama at Birmingham Heersink School of Medicine, shares histology update and revised nomenclature for OCT with Sheryl Stevenson of the Eye Care Network and Ophthalmology Times
SriniVas R. Sadda, MD, FARVO, shares key points from his retina presentation at the International SPECTRALIS Symposium
Robert Sergott, MD, describes fluorescence lifetime imaging ophthalmoscopy (FLIO) and the International SPECTRALIS Symposium – And Beyond (ISS) in Heidelberg, Germany.
Rayaz Malik, MBChB, PhD, a professor of medicine at Weill Cornell Medicine - Qatar, spoke with Ophthalmology Times Europe about his presentation. It's titled "An eye on neurodegenerative diseases: Challenging the dogma" at the International SPECTRALIS Sympsoium. In conversation with Hattie Hayes, Ophthalmology Times Europe
Anat Loewenstein, MD, describes her presentation on remote imaging for age-related macular degeneration and geographic atrophy at the International SPECTRALIS Symposium, in conversation with Hattie Hayes of Ophthalmology Times Europe
Tyson Brunstetter, OD, PhD, a US Navy Aerospace Optometrist at the NASA Johnson Space Center in Houston, Texas, shares key takeaways from his keynote at the International SPECTRALIS Symposium (ISS)
Rayaz Malik, MBChB, PhD, shares his presentation, titled An eye on neurodegenerative diseases: Challenging the dogma, at this year's International SPECTRALIS Symposium
At the Retina World Congress, Siegfried Priglinger, MD, speaks about ensuring the best outcomes for preschool-aged patients
At the 2025 ASCRS meeting, Robert Ang, MD said small aperture IOLs can benefit all patients, especially those with complex corneas or who have undergone previous corneal refractive surgery
Viha Vig, MBChB graduate student at the University of Auckland, New Zealand, discusses her poster presentation on the relationship between mitochondiral disease, Alzheimer disease, and other types of dementia.
© 2025 MJH Life Sciences

All rights reserved.